LEPORE, Vito
 Distribuzione geografica
Continente #
NA - Nord America 619
EU - Europa 110
AS - Asia 64
SA - Sud America 1
Totale 794
Nazione #
US - Stati Uniti d'America 615
SE - Svezia 36
CN - Cina 35
IT - Italia 27
SG - Singapore 19
DE - Germania 16
FI - Finlandia 10
GB - Regno Unito 10
BE - Belgio 4
CA - Canada 4
VN - Vietnam 4
FR - Francia 2
UA - Ucraina 2
AR - Argentina 1
BD - Bangladesh 1
HK - Hong Kong 1
IE - Irlanda 1
IN - India 1
IR - Iran 1
JP - Giappone 1
LT - Lituania 1
NL - Olanda 1
PH - Filippine 1
Totale 794
Città #
Fairfield 108
Woodbridge 78
Chandler 67
Ashburn 50
Seattle 45
Cambridge 39
Ann Arbor 32
Wilmington 32
Nyköping 29
Houston 27
Beijing 15
Munich 13
Singapore 12
Lawrence 9
Roxbury 9
Bari 8
Brooklyn 6
Des Moines 6
Falls Church 6
Princeton 6
Inglewood 5
London 5
Nanjing 5
Brussels 4
Dong Ket 4
Washington 4
Boardman 3
Frankfurt am Main 3
Montorso Vicentino 3
San Diego 3
Toronto 3
Hebei 2
Helsinki 2
Jacksonville 2
New York 2
Ostuni 2
Tianjin 2
Trani 2
Central 1
Changsha 1
Clearwater 1
Coimbatore 1
Dallas 1
Dhaka 1
Dublin 1
General Pacheco 1
Grottaglie 1
Guangzhou 1
Indiana 1
Isfahan 1
Jiaxing 1
Manila 1
Milan 1
Nanchang 1
Naples 1
Norwalk 1
Ottawa 1
Paris 1
Pieve di Cento 1
San Mateo 1
Shanghai 1
Shenyang 1
Tokyo 1
Wandsworth 1
Totale 679
Nome #
Reversible Cognitive Frailty, Dementia, and All-Cause Mortality. The Italian Longitudinal Study on Aging 146
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis 131
The use of immunosuppressant therapy for multiple sclerosis in Italy: A multicenter retroprospective study 96
Daily Function as Predictor of Dementia in Cognitive Impairment, No Dementia (CIND) and Mild Cognitive Impairment (MCI): An 8-Year Follow-Up in the ILSA Study 88
null 74
null 65
Detection of disability worsening in relapsing-remitting multiple sclerosis patients. A real-world roving EDSS-Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register 58
Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis 47
null 44
PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study 39
Isoelectric focusing and crossed immunoelectrofocusing of cerebrospinal fluid proteins in neurological disorders 24
Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study 20
null 18
Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register 13
Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression 4
Totale 867
Categoria #
all - tutte 3.798
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.798


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020117 0 0 0 0 0 13 15 19 19 16 30 5
2020/2021147 6 6 17 38 11 12 2 13 6 17 8 11
2021/202297 6 4 6 2 6 10 4 7 5 8 17 22
2022/2023143 18 23 13 6 17 23 1 15 22 0 3 2
2023/202472 2 10 7 17 10 13 1 1 1 2 1 7
2024/202553 13 4 16 16 3 1 0 0 0 0 0 0
Totale 867